73 related articles for article (PubMed ID: 14634046)
1. Effect of age on in vitro triazolam biotransformation in male human liver microsomes.
Patki KC; von Moltke LL; Harmatz JS; Hesse LM; Court MH; Greenblatt DJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):874-9. PubMed ID: 14634046
[TBL] [Abstract][Full Text] [Related]
2. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
3. Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomes.
Patki KC; Greenblatt DJ; von Moltke LL
J Pharm Pharmacol; 2004 Aug; 56(8):963-6. PubMed ID: 15285839
[TBL] [Abstract][Full Text] [Related]
4. Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
Warrington JS; Poku JW; von Moltke LL; Shader RI; Harmatz JS; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Mar; 292(3):1024-31. PubMed ID: 10688619
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney.
Warrington JS; Greenblatt DJ; von Moltke LL
J Pharmacol Exp Ther; 2004 May; 309(2):720-9. PubMed ID: 14742746
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
Patki KC; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Jul; 31(7):938-44. PubMed ID: 12814972
[TBL] [Abstract][Full Text] [Related]
7. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
Perloff MD; von Moltke LL; Cotreau MM; Greenblatt DJ
Biochem Pharmacol; 1999 Jun; 57(11):1227-32. PubMed ID: 10230766
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP3A enzymes in the biotransformation of triazolam in rat liver.
Warrington JS; Greenblatt DJ; Von Moltke LL
Xenobiotica; 2004 May; 34(5):463-71. PubMed ID: 15370962
[TBL] [Abstract][Full Text] [Related]
9. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice
Minegishi G; Kazuki Y; Yamasaki Y; Okuya F; Akita H; Oshimura M; Kobayashi K
Xenobiotica; 2019 Nov; 49(11):1303-1310. PubMed ID: 30561249
[TBL] [Abstract][Full Text] [Related]
11. The effect of age on sildenafil biotransformation in rat and mouse liver microsomes.
Warrington JS; von Moltke LL; Harmatz JS; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2003 Nov; 31(11):1306-9. PubMed ID: 14570760
[TBL] [Abstract][Full Text] [Related]
12. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance.
Foster JA; Houston JB; Hallifax D
Xenobiotica; 2011 Feb; 41(2):124-36. PubMed ID: 21058916
[TBL] [Abstract][Full Text] [Related]
14. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
James MO; Lou Z; Rowland-Faux L; Celander MC
Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of hepatic microsomal 3-hydroxylation of quinine in Adélie Penguins.
Numata M; Fawcett JP; Rosengren RJ; Wanwimolruk S
Comp Biochem Physiol C Toxicol Pharmacol; 2004 May; 138(1):53-8. PubMed ID: 15313446
[TBL] [Abstract][Full Text] [Related]
16. In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
Quintieri L; Fantin M; Palatini P; De Martin S; Rosato A; Caruso M; Geroni C; Floreani M
Biochem Pharmacol; 2008 Sep; 76(6):784-95. PubMed ID: 18671948
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
Brown HS; Griffin M; Houston JB
Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
[TBL] [Abstract][Full Text] [Related]
18. Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice.
Kudo T; Toda T; Ushiki T; Ohi K; Ikarashi N; Ochiai W; Sugiyama K
Xenobiotica; 2010 Apr; 40(4):282-90. PubMed ID: 20163193
[TBL] [Abstract][Full Text] [Related]
19. A study of the in vitro interaction between ethanol, and triazolam and its two metabolites using human liver microsomes.
Tanaka E; Nakamura T; Terada M; Shinozuka T; Honda K
J Clin Forensic Med; 2005 Oct; 12(5):245-8. PubMed ID: 16198966
[TBL] [Abstract][Full Text] [Related]
20. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection.
Chen Q; Tan E; Strauss JR; Zhang Z; Fenyk-Melody JE; Booth-Genthe C; Rushmore TH; Stearns RA; Evans DC; Baillie TA; Tang W
J Pharmacol Exp Ther; 2004 Oct; 311(1):307-14. PubMed ID: 15163679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
